Beta Bionics, Inc. Common Stock (BBNX) Stock
NASDAQ · BBNX
22.04
Fundamentals
Market cap
$1.15B
Price / Earnings ratio
-13.5x
Price / Sales ratio
8.3x
Price / Book ratio
3.8x
Return on assets
-0.2%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Beta Bionics, Inc. Common Stock
No description available.
SectorHealthcare
IndustryMedical Devices
Employees420
CEOMr. Sean T. Saint PE
IPO DateJan 30, 2025
HeadquartersIrvine, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Sean T. Saint PE | President, CEO & Director | 1976 |
| Mr. Stephen H. Feider | CFO, Treasurer & Secretary | 1990 |
| Mr. Mike Mensinger | Chief Product Officer | 1978 |
| Mr. David Henderson | Vice President of Operations | — |
| Blake Beber | Head of Investor Relations | — |
| Dr. Steven Russell M.D., Ph.D. | Chief Medical Officer | 1969 |
| Mr. Mark Hopman M.B.A., R.Ph. | Chief Commercial Officer | 1978 |
Fundamentals
Valuation
Market cap$1.15B
Price-to-sales ratio8.27
Price-to-book value3.84
Price-earnings ratio-13.50
Return on Equity-23.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-1.64
Income Statement
Average volume1,366,199
EBITDA$-63.18M
1 year high (52w)$32.71
1 year low (52w)$8.80
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



